Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers

被引:73
作者
Carroll, MF [1 ]
Schade, DS [1 ]
机构
[1] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
关键词
antioxidants; plasminogen activator inhibitor; protein; C reactive;
D O I
10.1161/01.CIR.0000074221.68903.77
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-This study was designed to determine the optimal timing of vitamins E and C to prevent oxidative stress induced by a high-fat evening meal in type 2 diabetes. Methods and Results-Eleven subjects were admitted on 4 occasions. Euglycemia was maintained for 24 hours by insulin infusion. Participants were fed a high-fat test supper equivalent to a McDonald's Big Mac Meal. Blood was drawn for measurement of C-reactive protein (CRP), interleukin 6 (IL-6), plasminogen activator inhibitor-1 (PAI-1), malonyldialdehyde (MDA), and total radical antioxidant parameter (TRAP) before and during the 4 hours after the test meal. Studies were performed in random sequence with vitamin E 800 IU and vitamin C 1 g given either before breakfast or before supper in a double-blind manner on the day of the test meal. Control studies were performed with no vitamins and no test meal administered. There was a significant rise in CRP and PAI-1 after the test supper (P<0.05 compared with "no meal"). Either presupper or prebreakfast vitamins E and C prevented the meal-induced rise in CRP (P=0.03), although presupper vitamins were more effective (P=0.03 compared with prebreakfast vitamins). Only prebreakfast vitamins prevented the meal-induced rise in PAI-1 (P=0.006). There were no significant meal-related changes in the concentrations of IL-6, MDA, or TRAP. Conclusions-The timing of administration of antioxidant vitamins has variable effects on markers of meal-induced inflammation and fibrinolysis. This observation may be one reason why cardiovascular disease prevention trials using these vitamins have reported conflicting results.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 35 条
[1]   POSTPRANDIAL PLASMA GLUCOSE, INSULIN, GLUCAGON AND TRIGLYCERIDE RESPONSES TO A STANDARD DIET IN NORMAL SUBJECTS [J].
AHMED, M ;
GANNON, MC ;
NUTTALL, FQ .
DIABETOLOGIA, 1976, 12 (01) :61-67
[2]   High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study [J].
Balkau, B ;
Shipley, M ;
Jarrett, RJ ;
Pyörälä, K ;
Pyörälä, M ;
Forhan, A ;
Eschwège, E .
DIABETES CARE, 1998, 21 (03) :360-367
[3]   Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[4]   Vitamin E:: function and metabolism [J].
Brigelius-Flohé, R ;
Traber, MG .
FASEB JOURNAL, 1999, 13 (10) :1145-1155
[5]   Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects [J].
Calles-Escandon, J ;
Mirza, SA ;
Sobel, BE ;
Schneider, DJ .
DIABETES, 1998, 47 (02) :290-293
[6]   Meal-generated oxidative stress in type 2 diabetic patients [J].
Ceriello, A ;
Lizzio, S ;
Bortolotti, N ;
Russo, A ;
Motz, E ;
Tonutti, L ;
Crescentini, A ;
Taboga, C .
DIABETES CARE, 1998, 21 (09) :1529-1533
[7]   Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications -: The effect of α-tocopherol supplementation [J].
Devaraj, S ;
Jialal, I .
CIRCULATION, 2000, 102 (02) :191-196
[8]   Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients [J].
Devaraj, S ;
Jialal, I .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (08) :790-792
[9]   α-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P-selectin levels in type 2 diabetic patients [J].
Devaraj, S ;
Chan, AVC ;
Jialal, I .
DIABETES CARE, 2002, 25 (03) :524-529
[10]   A FLUORESCENCE-BASED METHOD FOR MEASURING TOTAL PLASMA ANTIOXIDANT CAPABILITY [J].
GHISELLI, A ;
SERAFINI, M ;
MAIANI, G ;
AZZINI, E ;
FERROLUZZI, A .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (01) :29-36